The platelet activating factor (PAF) signaling cascade in systemic inflammatory responses

被引：119

作者：

Yost, Christian C. ^{[1
,2
]}

Weyrich, Andrew S. ^{[1
,3
]}

Zimmerman, Guy A. ^{[1
,3
]}

机构：

[1] Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA

[2] Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA

[3] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA

来源：

BIOCHIMIE | 2010年 / 92卷 / 06期

关键词：

Platelet-activating factor; Sepsis; Anaphylaxis; Inflammation; Lipid mediators; FACTOR RECEPTOR ANTAGONIST; RESPIRATORY-DISTRESS-SYNDROME; MULTIPLE ORGAN FAILURE; ACUTE LUNG INJURY; PHASE-II TRIAL; NF-KAPPA-B; FACTOR-ACETYLHYDROLASE; SEVERE SEPSIS; DOUBLE-BLIND; CLINICAL-TRIAL;

D O I：

10.1016/j.biochi.2010.02.011

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The platelet-activating factor (PAF) signaling cascade evolved as a component of the repertoire of innate host defenses, but is also an effector pathway in inflammatory and thrombotic diseases. This review focuses on the PAF signaling cascade in systemic inflammatory responses and, specifically, explores its activities in experimental and clinical sepsis and anaphylaxis in the context of the basic biochemistry and biology of signaling via this lipid mediator system. (C) 2010 Elsevier Masson SAS. All rights reserved.

引用

页码：692 / 697

页数：6

共 80 条

[61] Neonatal gut barrier and multiple organ failure: role of endotoxin and proinflammatory cytokines in sepsis and necrotizing enterocolitis [J].

Sharma, Renu ;

Tepas, Joseph J., III ;

Hudak, Mark L. ;

Mollitt, Daniel L. ;

Wludyka, Peter S. ;

Teng, Ru-Jeng ;

Premachandra, Bangalore R. .

JOURNAL OF PEDIATRIC SURGERY, 2007, 42 (03) :454-461

[62] Lipid Mediators in Health and Disease: Enzymes and Receptors as Therapeutic Targets for the Regulation of Immunity and Inflammation [J].

Shimizu, Takao .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2009, 49 :123-150

[63] Essential role of platelet-activating factor receptor in the pathogenesis of Dengue virus infection [J].

Souza, Danielle G. ;

Fagundes, Caio T. ;

Sousa, Lirlandia P. ;

Amaral, Flavio A. ;

Souza, Rafael S. ;

Souza, Adriano L. ;

Kroon, Erna G. ;

Sachs, Daniela ;

Cunha, Fernando Q. ;

Bukin, Eugenij ;

Atrasheuskaya, Alena ;

Ignatyev, George ;

Teixeira, Mauro M. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :14138-14143

[64] Biology of Platelet-activating Factor Acetylhydrolase (PAF-AH, Lipoprotein Associated Phospholipase A2) [J].

Stafforini, Diana M. .

CARDIOVASCULAR DRUGS AND THERAPY, 2009, 23 (01) :73-83

[65]

STAFFORINI DM, 1990, J BIOL CHEM, V265, P9682

[66] A double-blind placebo-controlled study of an infusion of lexipafant (platelet-activating factor receptor antagonist) in patients with severe sepsis [J].

Suputtamongkol, Y ;

Intaranongpai, S ;

Smith, MD ;

Angus, B ;

Chaowagul, W ;

Permpikul, C ;

Simpson, JA ;

Leelarasamee, A ;

Curtis, L ;

White, NJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) :693-696

[67]

TERASHITA ZI, 1987, J PHARMACOL EXP THER, V243, P378

[68] Platelet-activating factor acetylhydrolase and haemophagocytosis in the sepsis syndrome [J].

Trimoreau, F ;

François, B ;

Desachy, A ;

Besse, A ;

Vignon, P ;

Denizot, Y .

MEDIATORS OF INFLAMMATION, 2000, 9 (3-4) :197-200

[69] Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis [J].

Vadas, Peter ;

Gold, Milton ;

Perelman, Boris ;

Liss, Gary M. ;

Lack, Gideon ;

Blyth, Thomas ;

Simons, F. Estelle R. ;

Simons, Keith J. ;

Cass, Dan ;

Yeung, Jupiter .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (01) :28-35

[70] PAF-ACETHER TODAY - RELEVANCE FOR ACUTE EXPERIMENTAL ANAPHYLAXIS [J].

VARGAFTIG, BB ;

BRAQUET, PG .

BRITISH MEDICAL BULLETIN, 1987, 43 (02) :312-335

← 1 2 3 4 5 6 7 8 →